Archive for August 2023
Greentown Labs Houston hires former Entergy managing director as first general manager
Timmeko Moore Love joins Greentown Labs to build its Houston membership base as the city grows in the energy transition space. Read More
Read MoreMIT spinout FIGUR8 closes $25M round to analyze musculoskeletal health with AI
FIGUR8, which spun out of the MIT Media Lab, uses lightweight sensors, software and AI to analyze musculoskeletal health. Read More
Read MoreEduardo Crespo: A ‘preacher’ for Latino businesses
Through his marketing firm, Eduardo Crespo is continuing his longstanding advocacy for Latinos’ contributions to the economy. Read More
Read MoreAstellas signs lease at new Cambridge Crossing lab building
Astellas Pharma has agreed to take space on two floors of the newest lab site on DivcoWest’s sprawling mixed-use development. Read More
Read MoreThe Petri Dish: Agios licenses Alnylam drug, Ikena acquires startup with Gilead stake
Ikena Oncology is set to acquire a South San Francisco startup after Gilead Sciences waived its exclusive option to buy the company in March. Plus other life sciences news you may have missed. Read More
Read MoreFive things you need to know today and where are men left after ‘Barbie’?
Here are the five things you need to know in Boston business news to start your Thursday, as well as where the idea of "masculinity" is today, after #MeToo and "Barbie." Read More
Read MoreAvid Technology to go private in $1.4B deal
The deal is the latest in a streak of local publicly traded tech companies leaving the public markets this year, from Berkshire Grey to Duck Creek Technologies. Read More
Read MoreMass. equity efforts in the cannabis industry fall short
Massachusetts has touted itself as the first state with social equity regulations to make the marketplace more inclusive. Yet none of the largest retailers here are equity licenses. Read More
Read MoreEditorial: Mass. tax relief is still needed — and fast
Lawmakers shouldn’t mistake the newfound optimism among the state’s employers as a sign that meaningful and significant tax relief is no longer needed. Read More
Read MoreRegeneron to buy Boston-based hearing loss biotech for $213M
The Tarrytown, New York-based drugmaker has its sights set on Decibel Therapeutics, which develops gene therapies designed to treat various forms of hearing loss. Read More
Read More